Full Press Release Details
MORE INFORMATION: Alice
S. Chilton to Join BASi as Chief Operating Officer, Scientific
LAFAYETTE, IN, November 14, 2008 - Bioanalytical
Systems, Inc (Nasdaq: BASI) ("the Company") announced today that Anthony S.
Chilton, Ph.D., is joining the Company as Chief Operating Officer, Scientific
Services, effective December 1, 2008. Dr. Chilton will have responsibility
the scientific services provided to the Company's customers from three U.S. and
Chilton has over 30 years of experience as a scientist and executive in
life sciences companies in England, Canada and the United States. For the
two years, Dr. Chilton was in charge of early development programs at
Atherogenics, Inc. of Alpharetta, Ga. For the two years prior to that,
Chilton provided consulting and advisory services to various pharmaceutical
companies. Prior to that, he was Vice President of the Biopharmaceutical
Development Division of Cardinal Health Inc., which he joined through a
predecessor company in 1998 that was acquired by Cardinal in 2002. Previously,
Dr. Chilton spent three years with life sciences companies in Canada, prior
which he held positions in his native United Kingdom. Dr. Chilton received
bachelor's degree in Chemistry from the University of East Anglia in 1981, and
his Ph.D. in Analytical Chemistry from the University of Hertfordshire
of his compensation package, the Company has agreed to grant Dr. Chilton
incentive options to purchase 30,000 common shares under its 2008 Employee
Incentive Stock Option Plan at the per-share market price at the close
business on the last trading day prior to the date Dr. Chilton commences
employment with the Company. The option grants are contingent upon Dr.
commencing employment with the Company.
provides contract research services and unique analytical instruments to
world's leading drug development companies. The company focuses on developing
innovative services and products that increase efficiency and reduce the
taking new drugs to market. Visit www.BASInc.com
information about BASi.
release contains forward-looking statements that are subject to risks and
uncertainties including,
not limited to, risks and uncertainties related to the development of products
and services, the retention of key Company personnel, changes in technology,
industry standards and regulatory standards, and various market and operating
risks detailed in the Company's filings with the Securities and Exchange